Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors

por Montor, Wagner Ricardo, Salas, Andrei Ronaldo Oliveira Silva Escartin, Melo, Fabiana Henriques Machado de
Publicado 2018